Results 1 to 10 of about 1,796 (119)

Post biphosphonate mandible osteonecrosis: A case study and literature review [PDF]

open access: yesOral Oncology Reports, 2023
Purpose: Bisphosphonates have proven effective in reducing pain and skeletal events in bone metastases treatment. However, there is a long-term complication called osteonecrosis of the jaw, which has been reported for more than a decade.
Bambara H. Aboubacar   +5 more
doaj   +2 more sources

Intralesion Triamcinolon Injection Therapy on Esophageal Stricture as Side Effect of Long Term Use Biphosphonate [PDF]

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2017
Systemic Lupus Erythematous (SLE) is a chronic inflammatory disease that affect almost any organ system. Patient with SLE is at risk of osteoporosis. Biphosphonate is one of osteoporosis treatments. However, esophageal stricture (ES) caused by continuous
Arles, Yoanda Silvia
doaj   +2 more sources

Semi-Quantification of Myocardial Uptake of Bone-Seeking Agents in Suspected Cardiac Amyloidosis [PDF]

open access: yesJournal of Cardiovascular Development and Disease, 2023
Introduction: Bone scintigraphy has emerged as a key tool for non-invasive etiologic diagnosis of transthyretin (ATTR) cardiac amyloidosis (CA). We focused on a new semi-quantification method (on planar imaging) that could complement the qualitative ...
Cristina Campi   +8 more
doaj   +2 more sources

Alendronate overdose/intoxication: Suicidal attempt in a case report [PDF]

open access: yesEuropean Psychiatry, 2021
Introduction Alendronate is a nitrogen-containing biphosphonate that inhibits osteoclastic bone resorption. Lethal dose (LD50) was aproximately 626mg/kg in male rats, and 552mg/kg in female.
T. Gutiérrez Higueras   +3 more
doaj   +2 more sources

Case Report: A Novel Genetic Mutation Causes Idiopathic Infantile Arterial Calcification in Preterm Infants [PDF]

open access: yesFrontiers in Genetics, 2021
Idiopathic infantile arterial calcification (IIAC), also known as generalized arterial calcification of infancy (GACI), is a heritable ectopic mineralization disorder that results in diffuse arterial calcifications and or stenosis, which are attributed ...
Liu Yunfeng   +3 more
doaj   +2 more sources

Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report

open access: yesFrontiers in Pediatrics, 2022
Subcutaneous fat necrosis of the newborn (SCFN) is a panniculitis that develops in fatty areas after fetal or perinatal distress. Prognosis is generally good with complete regression, but it can be complicated by metabolic abnormalities like hypoglycemia,
Stefano Martinelli   +5 more
doaj   +1 more source

Oral Mucosal Ulcer Associated with Improper Usage of Bisphosphonate: A Case Report

open access: yesTürk Osteoporoz Dergisi, 2023
Bisphosphonates are widely used agents for osteoporosis. Although bisphosphonates are generally well-tolerated drugs, especially oral forms may have gastrointestinal system side effects.
Şeyma Nur Bayındır   +2 more
doaj   +1 more source

Bilateral Simultaneous Atypical Femoral Fracture: A Case Report

open access: yesCase Reports in Clinical Practice, 2022
We report a rare case of bilateral subtrochanteric femoral fracture related to prolonged treatment with Alendr onate. Bisphosphonates are the most common drugs used for treatment of osteoporosis and prevention of the risk of osteoporosis-related ...
Salman Ghaffari   +2 more
doaj   +1 more source

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma [PDF]

open access: yes, 2015
Bone lytic lesion in Multiple myeloma are the most commonly presented symptoms which require treatment with bisphosphonates (BPs). BPs are providing supportive care, reducing the rate of skeletal morbidity but evidently not abolishing it, the criteria ...
Alan Archibald (45342)   +21 more
core   +3 more sources

Oral bisphosphonate-associated osteonecrosis of maxillary bone: a review of 18 cases [PDF]

open access: yes, 2014
Biphosphonate-associated maxillary bone osteonecrosis (BPMO) is a complication related to nitrogen-containing biphosphonate therapy. This adverse effect occasionally appears in patients who are administered biphosphonates through intravenous infusion for
Escovich, Livia   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy